Big pharma “tax inversion” deal

Pharmaceutical giants Pfizer and Allergan are in merger talks that could bring blockbuster drugs like Pfizer’s Lyrica, Enbrel and Viagra, and Allergan’s Botox and Restasis under one corporate roof

Merger would create

world’s largest healthcare

group with market value of

Market

value

Market

value

$332 billion

$219bn

$113bn

Headquarters

Revenue (2014)

Number of employees

New York City, U.S.

$49.61bn

78,000

Dublin, Ireland

$72bn

30,000

Top-selling

medications

 

Lyrica – $5.16bn

(epilepsy, chronic pain)

Viagra – $1.68bn

(erectile dysfunction)

Botox – $2bn*

(anti-wrinkle treatment)

Restasis – $940bn*

(dry-eye treatment )

 

Tax inversion

deal:

U.S.

company buys

foreign company based

in low-tax jurisdiction and

moves headquarters there

to reduce its tax bill

35%

U.S. corporation tax:

Ireland corporation tax:

12.5%

Sources: Statista, Vault company-profiles

*2013 figures

© GRAPHIC NEWS

Big pharma in “tax inversion” deal

Pharmaceutical giants Pfizer and Allergan are in merger talks that could bring blockbuster drugs like Pfizer’s Lyrica, Enbrel and Viagra, and Allergan’s Botox and Restasis under one corporate roof

Pfizer market value

Allergan market

value

$219bn

$113bn

Merger would create world’s largest healthcare

group with market capitalisation of

$332 billion

Headquarters

Revenue (2014)

Number of employees

New York City, U.S.

$49.61bn

78,000

Top-selling

medications

 

Lyrica – $5.16bn

(epilepsy, chronic pain)

Viagra – $1.68bn

(erectile dysfunction)

Headquarters

Revenue (2014)

Number of employees

Dublin, Ireland

$72bn

30,000

Top-selling

medications

 

Botox – $2bn*

(anti-wrinkle treatment)

Restasis – $940bn*

(dry-eye treatment )

 

*2013

figures

U.S. company

Tax inversion deal:

buys foreign company based in

low-tax jurisdiction and moves

headquarters there to reduce its tax bill

35%

U.S. corporation tax:

Ireland corporation tax:

12.5%

Sources: Statista, Vault company-profiles

© GRAPHIC NEWS

Big pharma in “tax inversion” deal

Pharmaceutical giants Pfizer and Allergan are in merger talks that could bring blockbuster drugs like Pfizer’s Lyrica, Enbrel and Viagra, and Allergan’s Botox and Restasis under one corporate roof

Pfizer

market value

$219bn

Allergan

market value

$113bn

Merger would create world’s

largest healthcare group

with market capitalisation of

$332 billion

Headquarters

Revenue (2014)

Number of employees

Top-selling medications

 

New York City, U.S.

$49.61bn

78,000

Lyrica – $5.16bn

(epilepsy, chronic pain)

Viagra – $1.68bn

(erectile dysfunction)

Headquarters

Revenue (2014)

Number of employees

Top-selling medications

 

Dublin, Ireland

$72bn

30,000

Botox – $2bn*

(anti-wrinkle treatment)

Restasis – $940bn*

(dry-eye treatment )

 

Tax inversion deal:

U.S. company buys

foreign company

based in low-tax

jurisdiction and moves

headquarters there

to reduce its tax bill

35%

U.S. corporation tax:

Ireland corporation tax:

12.5%

Sources: Statista, Vault company-profiles

*2013 figures

© GRAPHIC NEWS